Rising to the challenge of treating high-risk patients

Robert M Guthrie1

  • 1College of Medicine and Public Health, Ohio State University, 146 Means, 1654 Upham Dr, Columbus, OH 43210, USA. Guthrie.1@osu.edu

Insights

High-risk patients benefit from lower LDL-C goals. Rosuvastatin therapy effectively helps patients achieve these cholesterol targets, improving cardiovascular health outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) guidelines emphasize lowering low-density lipoprotein cholesterol (LDL-C) in high-risk patients.
  • Major clinical trials confirm the benefit of LDL-C reduction below ATP III targets (<100 mg/dL) for high-risk individuals.
  • An optional, more aggressive LDL-C goal (<70 mg/dL) was suggested in 2004 for very high-risk patients, including those with diabetes or metabolic syndrome.

Purpose of the Study:

  • To evaluate the efficacy of rosuvastatin in achieving lower LDL-C goals compared to other statin monotherapies.
  • To assess the effectiveness of rosuvastatin in helping high-risk patients attain ATP III LDL-C targets.

Main Methods:

  • Analysis of recent large clinical trials comparing rosuvastatin with other statin monotherapies.
  • Review of data from the MERCURY (Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy) trials.

Main Results:

  • Rosuvastatin demonstrated greater LDL-C reduction compared to other statin monotherapies.
  • A significantly higher percentage of patients achieved their ATP III LDL-C targets when switched to rosuvastatin.
  • Rosuvastatin therapy improved goal attainment rates in high-risk patient populations.

Conclusions:

  • Rosuvastatin is effective in achieving aggressive LDL-C targets for high-risk patients.
  • Switching to rosuvastatin therapy can significantly improve cholesterol goal attainment.
  • These findings support the use of rosuvastatin in managing hyperlipidemia and reducing cardiovascular risk.

Related Concept Videos

Introduction To Health Care Delivery System01:18

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...